Ratings by BTIG (Thomas Schrader)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Tiziana Life Sciences | TLSA | New Coverage | Buy (N/A) |
0.93 (0.97) |
4.3% | Details | |
| 7/1/2026 | Serina THerapeutics | SER | New Coverage | Buy (N/A) |
1.94 (2.49) |
28.35% | Details | |
| 5/13/2026 | BioAge Labs Inc | BIOA | New Coverage | Buy (N/A) |
18.19 (8.94) |
-50.85% | Details | |
| 3/24/2026 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2025 | NRx Pharmaceuticals, Inc. | NRXP | New Coverage | Buy (N/A) |
1.94 (3.43) |
76.8% | Details | |
| 3/20/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Coya Therapeutics | COYA | New Coverage | Buy (N/A) |
5.76 (4.61) |
-19.97% | Details | |
| 10/5/2022 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2022 | Acumen Pharmaceuticals, Inc. | ABOS | New Coverage | Buy (N/A) |
6.26 (2.79) |
-55.43% | Details | |
| 5/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Replimune Group | REPL | New Coverage | Buy (N/A) |
45.42 (14.09) |
-68.98% | Details | |
| 7/27/2020 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
7.41 (7.25) |
-2.16% | Details | |
| 2/28/2020 | IMV Inc. | IMV | Maintain | Buy (N/A) |
|
Details |
